January 16, 2026 · Form 4 insider transaction
GOLDSTEIN DOV A MD bought 3,542 shares of BioAge Labs, Inc. at $4.38 per share, a transaction worth $15.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.